CN105664230A - Porous fiber intraoperative composite hemostatic material and preparation method thereof - Google Patents

Porous fiber intraoperative composite hemostatic material and preparation method thereof Download PDF

Info

Publication number
CN105664230A
CN105664230A CN201610042995.7A CN201610042995A CN105664230A CN 105664230 A CN105664230 A CN 105664230A CN 201610042995 A CN201610042995 A CN 201610042995A CN 105664230 A CN105664230 A CN 105664230A
Authority
CN
China
Prior art keywords
extract
hemostatic
blood
hemostatic material
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610042995.7A
Other languages
Chinese (zh)
Inventor
梁奕福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dongguan Da Qing Medical Devices Co Ltd
GUANGXI XINYE BIOLOGICAL TECHNOLOGY Co Ltd
Guangxi Daqing Biotechnology Co Ltd
Original Assignee
Dongguan Da Qing Medical Devices Co Ltd
GUANGXI XINYE BIOLOGICAL TECHNOLOGY Co Ltd
Guangxi Daqing Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongguan Da Qing Medical Devices Co Ltd, GUANGXI XINYE BIOLOGICAL TECHNOLOGY Co Ltd, Guangxi Daqing Biotechnology Co Ltd filed Critical Dongguan Da Qing Medical Devices Co Ltd
Priority to CN201610042995.7A priority Critical patent/CN105664230A/en
Publication of CN105664230A publication Critical patent/CN105664230A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043Mixtures of macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/66Papaveraceae (Poppy family), e.g. bloodroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/85Verbenaceae (Verbena family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0015Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Surgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to bio-medicine hemostatic materials, in particular to a porous fiber intraoperative composite hemostatic material and a preparation method thereof.The porous fiber intraoperative composite hemostatic material is composed of microporous starch, hyaluronic acid, puffball spore powder and hemostatic traditional Chinese medicine extract, the microporous starch has effect as a molecular sieve and can form instant gel to mechanically plug a blood vessel break, the hyaluronic acid can immediately absorb water in blood to form hydrogel so as to plug errhysis, and the puffball spore powder stores a lot of microporous fibers and can mechanically plug the blood vessel break.The three substances form a physical barrier to isolate a wound so as to play a role in adhesion preventing and immediate hemostasis, and the hemostatic traditional Chinese medicine extract has effect of stopping bleeding, resisting inflammation and bacteria, easing pain, cooling blood, dispersing stasis to diminish swelling, astringing, activating a coagulative system and promoting wound healing.The four substances are organically combined, so that hemostatic effect is enhanced remarkably.The porous fiber intraoperative composite hemostatic material is used for hemostasis of errhysis of various wounds and fresh tissue wounds, bleeding of small blood vessels and bleeding areas to prevent adhesion and is especially suitable for intraoperative hemostasis.

Description

Compound hemostatic material and its preparation method in a kind of multiporous fiber art
Technical field
The present invention relates to biological medicine hemostatic material technical field, it is specifically related to compound hemostatic material and its preparation method in a kind of multiporous fiber art.
Background technology
Hemostasis is an important step during each section office of hospital perform the operation, and plays sizable effect for the success of operation and the safety of patient. Normal hemostatic mechanism mainly comprises 3 aspects: the startup of the contraction of thin vessels, the activation of thrombocyte and blood coagulation system. Wherein, the contraction of thin vessels is the reaction the earliest of hemostasis after wound, and after vascular injury, vascular smooth muscle makes vasoconstriction, blood flow slow down by axon reflex, is conducive to blood coagulation and hemostasis. Thrombocyte has the physiological function adhering to wound and foreign matter surface, significant at primary hemostasis. The thrombocyte adhered to is activated, and may cause more platelet aggregation, and discharges a large amount of short solidifying thing from its inside, and then stops blooding being partially formed thrombocyte thrombus. Due to environmental factors or human body oneself factor, normal hemostatic mechanism can not save, for personal injury's large-area hemorrhage, the life that the wounded are about to disappearance. Therefore, the hemostatic material that research is stopped blooding rapidly is important research topic.
Traditional hemostatic material mainly comprises medicine bag, tourniquet, gauze etc. It is single that the surface of a wound is only played physical protection effect, function and effect by these auxiliary materials, and haemostatic effect is not good enough, and is easily adhered the surface of a wound.
Along with the development of technology, starch hemostatic material has occurred, such as the modified starch material that Chinese invention patent application discloses a kind of biocompatible hemostatic, anti, promoting healing, surgery are closed that application number is 200810032631.6, this hemostatic material is the mixture of esterification starch or one or more esterifications, cross-linking starch.The molecular weight of treated starch is 15,000 ~ 10,000,000, and particle diameter is 10 ~ 1000 μm, and water-intake rate is 1 ~ 100.
But these current technology haemostatic effects are undesirable, anthemorrhagic speed is fast not, limits it in clinical widespread use.
Summary of the invention
It is an object of the invention to for the deficiencies in the prior art, it is provided that a kind of anthemorrhagic speed is fast, haemostatic effect is specially adapted to well compound hemostatic material in the multiporous fiber art in performing the operation.
In order to realize above-mentioned purpose, the present invention adopts following technical scheme:
Compound hemostatic material in a kind of multiporous fiber art, in described multiporous fiber art, compound hemostatic material is made up of the raw material of following weight percent:
Micropore starch 20-40%
Hyaluronic acid 20-40%
Lasiosphaera fenzlii spore powder 20-40%
Hemostatic of traditional herb medicine extract 10-30%.
Preferably, in described multiporous fiber art, compound hemostatic material is made up of the raw material of following weight percent:
Micropore starch 20-35%
Hyaluronic acid 20-35%
Lasiosphaera fenzlii spore powder 20-35%
Hemostatic of traditional herb medicine extract 15-30%.
Preferably, the surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
Preferably, the pharmaceutical grade powder of hyaluronic acid to be molecular-weight average be 500-2000 dalton.
Preferably, described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 110-130 degree Celsius of drying, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
Preferably, described Hemostatic of traditional herb medicine extract is one or more mixture of Herba seu Radix Cirsii Japonici, Herba Cirsii extract, SIJIQING extract, Radix Sangusorbae extract, Ramie Root extract, Madder extract, Lignum Dalbergiae Odoriferae extract, Pseudobulbus Bletillae (Rhizoma Bletillae) extract, Receptaculum nelumbinis extract, rhizoma nelumbinis extract, Rhizoma Corydalis extract, Rhizoma Imperatae extract, Flos Sophorae extract, Cacumen Platycladi extract, Radix Notoginseng extract, Flos Celosiae Cristatae extract, Pollen Tyjphae extract, Crinis Carbonisatus extract, Herba Clinopodii extract, Herba Artemisiae Anomalae extract, Herba Agrimoniae extract, Folium Callicarpae Formosanae extract. Described Hemostatic of traditional herb medicine extract is commercially available.
Comparatively preferred, described Hemostatic of traditional herb medicine extract comprises the raw material of following weight part:
Herba seu Radix Cirsii Japonici 10-30 part
Herba Cirsii extract 20-40 part
Radix Sangusorbae extract 20-40 part
Ramie Root extract 10-30 part
Madder extract 5-10 part
Pseudobulbus Bletillae (Rhizoma Bletillae) extract 10-30 part
Receptaculum nelumbinis extract 20-40 part
Rhizoma nelumbinis extract 20-40 part
Rhizoma Imperatae extract 20-40 part
Flos Sophorae extract 10-30 part
Cacumen Platycladi extract 10-30 part
Radix Notoginseng extract 10-30 part
Pollen Tyjphae extract 10-30 part
Crinis Carbonisatus extract 5-10 part
Herba Clinopodii extract 5-10 part.
More preferred, described Hemostatic of traditional herb medicine extract also comprises the raw material of following weight part:
SIJIQING extract 10-30 part
Lignum Dalbergiae Odoriferae extract 5-10 part
Rhizoma Corydalis extract 20-40 part
Flos Celosiae Cristatae extract 10-30 part
Herba Artemisiae Anomalae extract 10-30 part
Herba Agrimoniae extract 20-40 part
Folium Callicarpae Formosanae extract 10-30 part.
A preparation method for compound hemostatic material in multiporous fiber art, is mixed to get compound hemostatic material in a kind of multiporous fiber art by micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract.
Preferably, micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 1-5 hour after mixing, ultrasonic activation can make that each raw material mixes evenly, and small portion Hemostatic of traditional herb medicine extract can enter into the duct of micropore starch, play the effect of lasting medicine release.
Described micropore starch is one or more the mixture in micropore yam starch, microporous tapioca, micropore sweet potato starch, micropore W-Gum, micropore barley starch, micropore wheat starch, micropore Starch rice.
Micropore starch derives from natural plant starch, good biocompatibility, and not containing animal source or humanized's composition, therefore irritated risk is little. Micropore starch has hydrophilic molecule filter screen effect, by the solids component assembled in blood, can form a kind of colloidal mixture, thus accelerate nature coagulation process around particle. These particles produce quick and strong blood clot by allowing blood shrink, and shorten the time for stopping blooding in operation greatly. Owing to starch is natural high molecular substance, can be absorbed by human body natural, thus can not leave in operation district and lead to complications.
Micropore starch has the effect of molecular sieve, can moisture in fast absorption blood, formed " instant gel ", can mechanicalness shutoff blood vessel cut, this physical barriers can isolate wound simultaneously, plays the effect of anti. The surface micropore diameter of preferred microporous starch is 6-15 μm, and the porosity of described micropore starch is more than 90%. Because affecting in the factor of the hemostatic capability of micropore starch, the size of water-retaining capacity is wherein one of important factor. And water-retaining capacity comes from, and the hole of micropore starch particle is how many and size. The present invention selects the micropore starch of suitable micro-pore diameter and voidage, more can moisture in fast absorption blood, play the effect of quick-acting haemostatic powder.
Hyaluronic acid demonstrates multiple important physiological function with the molecular structure of its uniqueness and physico-chemical property in body, and the hyaluronic acid of the present invention has the permeability, Water-Electrolyte diffusion and the effect such as running, promotion wound healing that regulate vessel wall. Preferably transparent matter acid employing molecular-weight average is the pharmaceutical grade powder of 500-2000 dalton; Owing to the purity of hyaluronic acid, molecular weight can directly affect the result of use of hyaluronic acid, so the present invention selects molecular-weight average to be the pharmaceutical grade powder of 500-2000 dalton.
Lasiosphaera fenzlii, nature and flavor are pungent, flat, nontoxic, containing Argine Monohydrochloride, the acid of cheese base, urea, ergosterol, lipoids, calvacin etc., have anti-inflammatory, antibacterial, the effect stopped blooding. Preferred Lasiosphaera fenzlii spore powder refers to peels off outer foreskin by Lasiosphaera fenzlii, digs out content and sifts out spore, by spore 110-130 degree Celsius of drying, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing. Lasiosphaera fenzlii spore powder through above process has better antibacterial, haemostatic effect. Lasiosphaera fenzlii spore powder stores a large amount of micro-multiporous fiber, can the moisture in absorbing blood rapidly, mechanicalness shutoff blood vessel cut and capillary vessel can ooze blood, this physical barriers can isolate wound simultaneously, plays the effect of instant hemostasis.
Hemostatic of traditional herb medicine extract of the present invention has following effect:
Setose thistle in Herba seu Radix Cirsii Japonici: nature and flavor are sweet, bitter, cool; Gui Jing: the thoughts of returning home, Liver Channel; Effect: cooling blood for hemostasis, removing blood stasis to reduce swelling; Curing mainly: for bleeding from five sense organs or subcutaneous tissue, spit blood, hematuria, has blood in stool, uterine bleeding, traumatic hemorrhage, carbuncle sore tumefacting virus.
Field thistle in Herba Cirsii extract, sweet, bitter, cool. The thoughts of returning home, Liver Channel. Function with cure mainly: cooling blood for hemostasis, removing blood stasis to reduce swelling. For bleeding from five sense organs or subcutaneous tissue, spitting blood, hematuria, has blood in stool, metrostaxis, traumatic hemorrhage, carbuncle sore tumefacting virus.
Folium ilicis chinensis in SIJIQING extract, has clearing heat and detoxicating; Promoting tissue regeneration and ulcer healing;Effect of promoting blood circulation and hemostasis.
Garden burnet in Radix Sangusorbae extract: have cooling blood for hemostasis, clearing heat and detoxicating, effect of detumescence sore, cures mainly haematemesis, and spitting of blood, bleeding from five sense organs or subcutaneous tissue, hematuria, has blood in stool, hemorrhoid blood, bloody flux, uterine bleeding, leucorrhea with red and white discharge, sore, carbuncle and painful swelling, eczema, pruritus vulvae, burn due to hot liquid or fire, the diseases such as snake bite and insect sting.
Ramie Root in Ramie Root extract, taste is sweet, flat. Control pyreticosis greatly yearningly, mad greatly, blood drench, the retention of urine, spit blood, lower blood, leucorrhea with red and white discharge, erysipelas, carbuncle swell, wound, snake bite and insect sting.
Madder in Madder extract: bitter, cold, return Liver Channel. Having cool blood, hemostasis, the stasis of blood of dispelling, stimulates the menstrual flow, antibechic, the effect eliminated the phlegm. For spitting blood, bleeding from five sense organs or subcutaneous tissue, uterine bleeding, traumatic hemorrhage, through closing stasis blocking, arthralgia, tumbling and swelling.
I.e. chrysanthemum pears root heartwood falls perfume (or spice), in Lignum Dalbergiae Odoriferae extract, for medicinal. For good analgesic agent, control again knife wound hemorrhage.
White in Pseudobulbus Bletillae (Rhizoma Bletillae) extract and: pungent, bitter, sweet, puckery, micro-cold. Return lung, liver, stomach warp. There is the effect of hemostasis tonifying lung, myogenic pain relieving.
Lotus pod in Receptaculum nelumbinis extract: pained, temperature. There is the stasis of blood that disappears, hemostasis, the effect dried. Controlling metrorrhagia, menorrhagia, blood under threatened abortion, hemostasis is suffered from abdominal pain, postpartum retention of placenta, bloody flux, blood drenches, hemorrhoid prolapse of the anus, and skin wets sore.
Rhizoma nelumbinis in rhizoma nelumbinis extract: cool, sweet. Raw product clearing heat and promoting fluid, cooling blood for hemostasis; Ripe help taste, benefit blood myogenic.
Yanhusuo in Rhizoma Corydalis extract has invigorates blood circulation, promoting the circulation of qi, effect of pain relieving. For chest the side of body, epigastric pain, Obstruction of qi in the chest and cardialgia, through closing dysmenorrhoea, postpartum stasis blocking, tumbling and swelling.
Rhizome of Lalang Grass in Rhizoma Imperatae extract: nature and flavor are sweet, cold; Gui Jing: return lung, stomach, bladder warp; Effect: cooling blood for hemostasis, clearing away heat and promoting diuresis; Curing mainly: spit blood for blood-head, bleeding from five sense organs or subcutaneous tissue, hematuria, pyreticosis polydipsia, cough due to lung-heat, gastropyretic vomiting, jaundice due to damp-heat, oedema urine is few, and heat drenches puckery pain.
Sophora flower in Flos Sophorae extract: bitter, cold nature, returns liver, large intestine channel; Effect: cooling blood for hemostasis, clearing liver-fire; Curing mainly: discharging fresh blood stool, hemorrhoid blood, bloody flux, hematuria, blood drenches, uterine bleeding, spits blood, bleeding from five sense organs or subcutaneous tissue, and irascibility is had a headache, conjunctival congestion with pain and swelling of the eye, larynx numbness, aphonia, ulcer sores.
Leafy twigs of Oriental Arborvitae in Cacumen Platycladi extract: nature and flavor are bitter, puckery, cold; Gui Jing: return lung, liver, the spleen channel; Effect: cooling blood for hemostasis, preventing phlegm from forming and stopping coughing, growing and blacking hair; Curing mainly: for spitting blood, bleeding from five sense organs or subcutaneous tissue, spitting of blood, has blood in stool, metrostaxis, cough due to lung-heat, blood-head alopecia, early whitening of beard and hair.
Pseudo-ginseng in Radix Notoginseng extract, nature and flavor, hardship sweet, micro-, temperature. Gui Jing, returns liver, stomach warp. Effect, loose stasis of blood hemostasis, subduing swelling and relieving pain. Curing mainly, for spitting of blood, spit blood, bleeding from five sense organs or subcutaneous tissue, has blood in stool, uterine bleeding, traumatic hemorrhage, chest and abdomen shouting pain, tumbling and swelling.
Flos Celosiae Cristatae in Flos Celosiae Cristatae extract, sweet, cool, nontoxic. Enter kidney channel, cool blood, hemostasis. Controlling blood under anal fistula, red white lower dysentery, spit blood, hemoptysis, blood drenches, women's metrorrhagia, leucorrhea with red and white discharge.
Cattail pollen in Pollen Tyjphae extract, taste is sweet, micro-pungent; Property is put down, and has blood-cooling hemostatic; Effect of blood circulation and stasis-eliminating medicine, cures mainly haematemesis; Spitting of blood; Bleeding from five sense organs or subcutaneous tissue; Standby dysentery; Have blood in stool; Uterine bleeding; Traumatic hemorrhage; Trusted subordinate's pain; Through closing stomachache; Postpartum the stasis of blood pain; Dysmenorrhoea; Tumbling and swelling; Blood strangury and dry pain; Under band; Double tongue; Aphtha; Ear; Uncontrolled urination is itched.
Crinis Carbonisatus in Crinis Carbonisatus extract, nature and flavor are bitter, flat. Gui Jing returns liver, stomach warp. Effect astringing to arrest bleeding, stagnation resolvation, diuresis. Curing mainly for spitting blood, spitting of blood, bleeding from five sense organs or subcutaneous tissue, blood drenches, and hematuria, has blood in stool, uterine bleeding, traumatic hemorrhage, dysuria.
Herba Clinopodii in Herba Clinopodii extract is micro-hardship, puckery, cool.Return Liver Channel. Effect: astringing to arrest bleeding. For uterine bleeding, hematuria, nosebleed epistaxis, gingival hemorrhage, wound hemorrhage.
The Herba Artemisiae Anomalae of Herba Artemisiae Anomalae extract, meridian distribution of property and flavor: bitter. Temperature, the thoughts of returning home, liver, the spleen channel. Broken blood stimulates the menstrual flow, healing up sore and subduing swelling. Control through closing abdominal mass, chest abdominal distention and pain, postpartum the blood stasis of blood, wound, metal-inflicted wound is hemorrhage, and carbuncle poison is swollen.
Herba Agrimoniae in Herba Agrimoniae extract, bitter, puckery, tepor, flat. The thoughts of returning home, Liver Channel. Having and hold back hemostasis, only dysentery, kills effect of worm. Extensively for various hemorrhage card, such as: haematemesiss, hematuria, have blood in stool, uterine bleeding, spitting of blood, bleeding from five sense organs or subcutaneous tissue, dysentery, internal lesion caused by overexertion take off power, and carbuncle is swollen, falls dozen, the diseases such as wound hemorrhage.
Folium Callicarpae Formosanae in Folium Callicarpae Formosanae extract is pungent, bitter, flat. Return liver, spleen, stomach warp. Function: loose stasis of blood hemostasis, swelling and pain relieving. Leaf: for spitting blood, spitting of blood, bleeding from five sense organs or subcutaneous tissue, has blood in stool; External curing traumatic hemorrhage. Root: treating swelling and pain by traumatic injury, treating rheumatic ostealgia.
Above Chinese medicine all has the effect of hemostasis, single use can also, after compatibility, result of use is better. Hemostatic of traditional herb medicine extract is carried out suitable compatibility by the present invention; the existing Chinese medicine that local vascular is shunk and stop blooding, such as pseudo-ginseng, Folium Callicarpae Formosanae, field thistle, also acts on coagulation process, shortens the clotting time; increase platelet count and short solidifying Chinese medicine, such as Herba Agrimoniae, Folium Callicarpae Formosanae; Also having and strengthen Platelet factorⅢ activity, the shortening thrombokinase generation time, such as the bletilla striata; Having and increase zymoplasm in blood, such as pseudo-ginseng, cattail pollen, more have and can improve vessel wall function, strengthen capillary vessel to the resistibility of damage, the Chinese medicine reducing vascular permeability is such as sophora flower. Suppress the activity of Tryptase (plasmin): as white and, setose thistle, field thistle, garden burnet, Herba Agrimoniae. The one side that the existing promotion blood such as pseudo-ginseng, madder, cattail pollen are solidifying, also has and impels clot dissolution effect, and its function has hemostasis and promoting blood circulation to remove blood stasis function concurrently, is conducive to hemostasis and does not stay the stasis of blood, is specially adapted to hemostatic material. To sum up, various Chinese medicine is learnt from other's strong points to offset one's weaknesses, and has played maximum effect, has hemostasis, anti-inflammation, antibacterial, analgesia, cool blood, dissipating blood stasis for subsidence of swelling, convergence, activation blood coagulation system, promotes the effect of wound healing.
Compared with prior art, useful effect is in the present invention:
(1) micropore starch of the present invention has the effect of molecular sieve, can moisture in fast absorption blood, formed " instant gel ", mechanicalness shutoff blood vessel cut; Hyaluronic acid can immediately in absorbing blood moisture form hydrogel, thus blood is oozed in shutoff; Lasiosphaera fenzlii spore powder stores a large amount of micro-multiporous fiber, can the moisture in absorbing blood rapidly, mechanicalness shutoff blood vessel cut and capillary vessel can ooze blood, micropore starch, hyaluronic acid, this three of Lasiosphaera fenzlii spore powder form physical barriers jointly, wound can be isolated, play anti and the effect of instant hemostasis. Hemostatic of traditional herb medicine extract then has hemostasis, anti-inflammation, antibacterial, analgesia, cool blood, dissipating blood stasis for subsidence of swelling, convergence, activation blood coagulation system, promotes the effect of wound healing. The present invention's four kinds of materials organically combine, and significantly strengthen haemostatic effect, and anthemorrhagic speed significantly improves, and oozes the hemostasis in blood, the hemorrhage and hemorrhage district of thin vessels for various wound and the flesh tissue surface of a wound, Film with Preventing Adhesion, the hemostasis being specially adapted in performing the operation.
(2) in the multiporous fiber art of the present invention, compound hemostatic material biocompatibility meets GB/T16886.11-2011 requirement, and in multiporous fiber art, compound hemostatic material microbiological indicator meets GB15979-2002 requirement.
(3) the present invention can stop blooding rapidly, and the gel viscosity of formation is higher, can clog damaged tissue and blood vessel, and the present invention is easily swelling and cleaning in water, and residue greatly reduces; The present invention is stable and not easily decomposes, long preservative period, has storage advantage.
Embodiment
Below in conjunction with embodiment, the present invention is further illustrated.
Embodiment 1.
Compound hemostatic material in a kind of multiporous fiber art, is made up of the raw material of following weight percent:
Micropore starch 20%
Hyaluronic acid 40%
Lasiosphaera fenzlii spore powder 20%
Hemostatic of traditional herb medicine extract 20%.
The surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
The pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 500 dalton.
Described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 110 degrees Celsius of dryings, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
Described Hemostatic of traditional herb medicine extract is 10 parts of Herba seu Radix Cirsii Japonicis and the mixture of 20 parts of Herba Cirsii extract compositions.
Above-mentioned micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
Embodiment 2.
Compound hemostatic material in a kind of multiporous fiber art, is made up of the raw material of following weight percent:
Micropore starch 40%
Hyaluronic acid 20%
Lasiosphaera fenzlii spore powder 25%
Hemostatic of traditional herb medicine extract 15%.
The surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
The pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 1000 dalton.
Described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 120 degrees Celsius of dryings, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
The mixture that described Hemostatic of traditional herb medicine extract is made up of 20 parts of Radix Sangusorbae extracts, 40 parts of Ramie Root extracts, 30 parts of Flos Sophorae extracts, 30 parts of Pollen Tyjphae extracts, 25 parts of Herba Agrimoniae extracts.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 2 hours after mixing.
Embodiment 3.
Compound hemostatic material in a kind of multiporous fiber art, is made up of the raw material of following weight percent:
Micropore starch 30%
Hyaluronic acid 25%
Lasiosphaera fenzlii spore powder 20%
Hemostatic of traditional herb medicine extract 25%.
The surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
The pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 2000 dalton.
Described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 130 degrees Celsius of dryings, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
Described Hemostatic of traditional herb medicine extract is the mixture of 10 parts of Radix Sangusorbae extracts, 20 parts of Madder extracts, 20 parts of Rhizoma Imperatae extracts, 10 parts of Flos Celosiae Cristatae extracts, 20 parts of Herba Clinopodii extracts, 5 parts of Herba Artemisiae Anomalae extracts, 10 parts of Folium Callicarpae Formosanae extract compositions.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 5 hours after mixing.
Embodiment 4.
Compound hemostatic material in a kind of multiporous fiber art, is made up of the raw material of following weight percent:
Micropore starch 35%
Hyaluronic acid 25%
Lasiosphaera fenzlii spore powder 20%
Hemostatic of traditional herb medicine extract 20%.
The surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
The pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 800 dalton.
Described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 130 degrees Celsius of dryings, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
Described Hemostatic of traditional herb medicine extract is made up of the raw material of following weight part:
Herba seu Radix Cirsii Japonici 10 parts
Herba Cirsii extract 40 parts
Radix Sangusorbae extract 20 parts
Ramie Root extract 30 parts
Madder extract 5 parts
Pseudobulbus Bletillae (Rhizoma Bletillae) extract 30 parts
Receptaculum nelumbinis extract 20 parts
Rhizoma nelumbinis extract 40 parts
Rhizoma Imperatae extract 20 parts
Flos Sophorae extract 30 parts
Cacumen Platycladi extract 10 parts
Radix Notoginseng extract 30 parts
Pollen Tyjphae extract 10 parts
Crinis Carbonisatus extract 10 parts
Herba Clinopodii extract 5 parts.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 3 hours after mixing.
Embodiment 5.
Compound hemostatic material in a kind of multiporous fiber art, is made up of the raw material of following weight percent:
Micropore starch 40%
Hyaluronic acid 20%
Lasiosphaera fenzlii spore powder 30%
Hemostatic of traditional herb medicine extract 10%.
The surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
The pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 1200 dalton.
Described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 120 degrees Celsius of dryings, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
Described Hemostatic of traditional herb medicine extract comprises the raw material of following weight part:
Herba seu Radix Cirsii Japonici 30 parts
Herba Cirsii extract 20 parts
Radix Sangusorbae extract 40 parts
Ramie Root extract 10 parts
Madder extract 10 parts
Pseudobulbus Bletillae (Rhizoma Bletillae) extract 10 parts
Receptaculum nelumbinis extract 40 parts
Rhizoma nelumbinis extract 20 parts
Rhizoma Imperatae extract 40 parts
Flos Sophorae extract 10 parts
Cacumen Platycladi extract 30 parts
Radix Notoginseng extract 10 parts
Pollen Tyjphae extract 30 parts
Crinis Carbonisatus extract 5 parts
Herba Clinopodii extract 10 parts.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 4 hours after mixing.
Embodiment 6.
Compound hemostatic material in a kind of multiporous fiber art, is made up of the raw material of following weight percent:
Micropore starch 35%
Hyaluronic acid 30%
Lasiosphaera fenzlii spore powder 20%
Hemostatic of traditional herb medicine extract 15%.
The surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
The pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 1800 dalton.
Described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 120 degrees Celsius of dryings, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
Described Hemostatic of traditional herb medicine extract comprises the raw material of following weight part:
Herba seu Radix Cirsii Japonici 30 parts
Herba Cirsii extract 20 parts
Radix Sangusorbae extract 20 parts
Ramie Root extract 30 parts
Madder extract 5 parts
Pseudobulbus Bletillae (Rhizoma Bletillae) extract 10 parts
Receptaculum nelumbinis extract 40 parts
Rhizoma nelumbinis extract 20 parts
Rhizoma Imperatae extract 20 parts
Flos Sophorae extract 30 parts
Cacumen Platycladi extract 10 parts
Radix Notoginseng extract 10 parts
Pollen Tyjphae extract 30 parts
Crinis Carbonisatus extract 5 parts
Herba Clinopodii extract 5 parts.
SIJIQING extract 30 parts
Lignum Dalbergiae Odoriferae extract 5 parts
Rhizoma Corydalis extract 20 parts
Flos Celosiae Cristatae extract 30 parts
Herba Artemisiae Anomalae extract 10 parts
Herba Agrimoniae extract 20 parts
Folium Callicarpae Formosanae extract 30 parts.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 5 hours after mixing.
Embodiment 7.
Compound hemostatic material in a kind of multiporous fiber art, is made up of the raw material of following weight percent:
Micropore starch 30%
Hyaluronic acid 20%
Lasiosphaera fenzlii spore powder 30%
Hemostatic of traditional herb medicine extract 20%.
The surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
The pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 500 dalton.
Described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 120 degrees Celsius of dryings, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
Described Hemostatic of traditional herb medicine extract comprises the raw material of following weight part:
Herba seu Radix Cirsii Japonici 20 parts
Herba Cirsii extract 30 parts
Radix Sangusorbae extract 30 parts
Ramie Root extract 20 parts
Madder extract 8 parts
Pseudobulbus Bletillae (Rhizoma Bletillae) extract 20 parts
Receptaculum nelumbinis extract 30 parts
Rhizoma nelumbinis extract 30 parts
Rhizoma Imperatae extract 30 parts
Flos Sophorae extract 20 parts
Cacumen Platycladi extract 20 parts
Radix Notoginseng extract 20 parts
Pollen Tyjphae extract 20 parts
Crinis Carbonisatus extract 8 parts
Herba Clinopodii extract 8 parts.
SIJIQING extract 20 parts
Lignum Dalbergiae Odoriferae extract 8 parts
Rhizoma Corydalis extract 25 parts
Flos Celosiae Cristatae extract 15 parts
Herba Artemisiae Anomalae extract 25 parts
Herba Agrimoniae extract 30 parts
Folium Callicarpae Formosanae extract 25 parts.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 3 hours after mixing.
Embodiment 8.
Compound hemostatic material in a kind of multiporous fiber art, is made up of the raw material of following weight percent:
Micropore starch 25%
Hyaluronic acid 35%
Lasiosphaera fenzlii spore powder 25%
Hemostatic of traditional herb medicine extract 15%.
The surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
The pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 900 dalton.
Described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, digs out content and sifts out spore, by spore 120 degrees Celsius of dryings, crosses the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth after pulverizing.
Described Hemostatic of traditional herb medicine extract comprises the raw material of following weight part:
Herba seu Radix Cirsii Japonici 10 parts
Herba Cirsii extract 40 parts
Radix Sangusorbae extract 40 parts
Ramie Root extract 10 parts
Madder extract 10 parts
Pseudobulbus Bletillae (Rhizoma Bletillae) extract 30 parts
Receptaculum nelumbinis extract 20 parts
Rhizoma nelumbinis extract 40 parts
Rhizoma Imperatae extract 40 parts
Flos Sophorae extract 10 parts
Cacumen Platycladi extract 30 parts
Radix Notoginseng extract 30 parts
Pollen Tyjphae extract 10 parts
Crinis Carbonisatus extract 10 parts
Herba Clinopodii extract 10 parts.
SIJIQING extract 10 parts
Lignum Dalbergiae Odoriferae extract 10 parts
Rhizoma Corydalis extract 40 parts
Flos Celosiae Cristatae extract 10 parts
Herba Artemisiae Anomalae extract 30 parts
Herba Agrimoniae extract 40 parts
Folium Callicarpae Formosanae extract 10 parts.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
Micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 5 hours after mixing.
Hemostasis usefulness measures and compares:
Laboratory animal and grouping are grown up healthy rabbits 50 (offer of Guangxi Medical University's experimentation on animals center), and body weight 2.5-3kg, male and female are not limit, experimental group and control group, often organize each 25, in each pressing time section each 5. Every rabbit both sides kidney makes long 1cm, and the dark hemorrhage surface of a wound of 0.5cm size, stops blooding to the hemorrhage surface of a wound with the hemostatic material of embodiment of the present invention 1-8 at random, taking Arista styptic powder to the hemostasis of another side surface of a wound as comparison. Experimental group is the application of embodiment of the present invention 1-8 hemostatic material, and control group is the application of Arista styptic powder.
Experimental technique and observation index
Hemorrhage Modelling: 3% pentobarbital sodium inj (30-40mg/kg) is anaesthetized along family's rabbit ear along intravenous injection, experiment table has been fixed rabbit, aseptic technique opens abdomen by layer, expose rabbit kidney, two longitudinal incisioies are made at kidney different positions at random with knife blade, long about 1cm, dark about 0.5cm, cutting part blood was with after claiming the dry gauze of weight to blot, with the hemostatic material of 1g embodiment of the present invention 1-8, the hemorrhage surface of a wound is stopped blooding at random, taking 1gArista powder to the hemostasis of another side surface of a wound as comparison, use the gauze pressing surface of a wound, oppress 10s respectively, 20s, 30s, 40s, 50s also records amount of bleeding and the bleeding stopping period of each time group.
Hemorrhage index observing
The bleeding stopping period kidney hemorrhagic disease surface of a wound is observed: calculates and is applied to the surface of a wound to surface of a wound blood from the present invention or Arista styptic powder and oozes out stopping or the red dye area of styptic powder particle no longer expands and is recorded as bleeding stopping period.
Amount of bleeding analytical balance accurate weighing experimental group and the front dry gauze weight rear with hemostasis of control group hemostasis in advance, calculates amount of bleeding (the front weight/blood proportion of the rear weight-hemostasis of amount of bleeding=hemostasis) respectively.
Result: general proterties and ultrastructure: the hemostatic material of the present invention is white powder particle, visual inspection, granular size equal one, relatively Arista styptic powder is fine and smooth for grain pattern, under scanning electron microscope, starch granules diameter is about 20 μm, and there is multiple pore passage structure inside, aperture is about 1.5 μm, and pore size is substantially identical. Arista styptic powder is white powder particle, and under scanning electron microscope, visible particle surface is made up of multiple crack, and without pore passage structure, particle volume is about 1-2 times of the present invention.
Experimental result shows, and when oppressing 10s, 20s, kidney hemorrhagic disease amount is big, and the bleeding time is long. Pressing time is more than, after 30s, amount of bleeding and bleeding time change are obvious, and both obviously shorten, and after compressing 40s, 50s, hemorrhage index rangeability reduces further. Experimental data shows: experimental group and control group all need compressing more than 30s, and haemostatic effect could embody. Table 1 is in different pressing time, the hemostatic material of embodiment of the present invention 1-8 and the comparison of Arista styptic powder amount of bleeding and bleeding stopping period.
Table 1
Can find out that haemostatic effect of the present invention is obviously better than Arista styptic powder by table 1.
Haemostatic effect gross examination of skeletal muscle
After exposing kidney, after otch is performed an operation on normal kidney surface, blood is gushed out rapidly, after blotting blood with dry gauze, spills the styptic powder of 1g the present invention fast, and hemorrhage district starch turns red immediately by white, and dry gauze continues compressing. 20s compressing group, removes gauze, and the hemorrhage surface of a wound has a small amount of blood to ooze out, and the red dye area of styptic powder of the present invention slowly expands;30s compressing group, the hemorrhage basic stopping of kidney otch, without obvious oozing phenomenon; 40s and 50s compressing group, after removing gauze, it is seen that the styptic powder of the present invention attaches to cut surface in the pasty state, stopped bleeding.
Finally should be noted that; above embodiment is only in order to illustrate the technical scheme of the present invention; but not limiting the scope of the invention; although having done to explain to the present invention with reference to better embodiment; it will be understood by those within the art that; the technical scheme of the present invention can be modified or equivalent replacement, and not depart from essence and the scope of technical solution of the present invention.

Claims (10)

1. compound hemostatic material in a multiporous fiber art, it is characterised in that: in this multiporous fiber art, compound hemostatic material is made up of the raw material of following weight percent:
Micropore starch 20-40%
Hyaluronic acid 20-40%
Lasiosphaera fenzlii spore powder 20-40%
Hemostatic of traditional herb medicine extract 10-30%.
2. compound hemostatic material in a kind of multiporous fiber art according to claim 1, it is characterised in that: in this multiporous fiber art, compound hemostatic material is made up of the raw material of following weight percent:
Micropore starch 20-35%
Hyaluronic acid 20-35%
Lasiosphaera fenzlii spore powder 20-35%
Hemostatic of traditional herb medicine extract 15-30%.
3. compound hemostatic material in a kind of multiporous fiber art according to claim 1, it is characterised in that: the surface micropore diameter of described micropore starch is 6-15 μm, and the porosity of described micropore starch is more than 90%.
4. compound hemostatic material in a kind of multiporous fiber art according to claim 1, it is characterised in that: the pharmaceutical grade powder of described hyaluronic acid to be molecular-weight average be 500-2000 dalton.
5. compound hemostatic material in a kind of multiporous fiber art according to claim 1, it is characterized in that: described Lasiosphaera fenzlii spore powder is that Lasiosphaera fenzlii is peelled off outer foreskin, dig out content and sift out spore, by spore 110-130 degree Celsius of drying, after pulverizing, cross the Lasiosphaera fenzlii spore powder that 100 orders obtain with upper screen cloth.
6. compound hemostatic material in a kind of multiporous fiber art according to claim 1, it is characterized in that: described Hemostatic of traditional herb medicine extract is Herba seu Radix Cirsii Japonici, Herba Cirsii extract, SIJIQING extract, Radix Sangusorbae extract, Ramie Root extract, Madder extract, Lignum Dalbergiae Odoriferae extract, Pseudobulbus Bletillae (Rhizoma Bletillae) extract, Receptaculum nelumbinis extract, rhizoma nelumbinis extract, Rhizoma Corydalis extract, Rhizoma Imperatae extract, Flos Sophorae extract, Cacumen Platycladi extract, Radix Notoginseng extract, Flos Celosiae Cristatae extract, Pollen Tyjphae extract, Crinis Carbonisatus extract, Herba Clinopodii extract, Herba Artemisiae Anomalae extract, Herba Agrimoniae extract, one or more mixture of Folium Callicarpae Formosanae extract.
7. compound hemostatic material in a kind of multiporous fiber art according to claim 6, it is characterised in that: described Hemostatic of traditional herb medicine extract comprises the raw material of following weight part:
Herba seu Radix Cirsii Japonici 10-30 part
Herba Cirsii extract 20-40 part
Radix Sangusorbae extract 20-40 part
Ramie Root extract 10-30 part
Madder extract 5-10 part
Pseudobulbus Bletillae (Rhizoma Bletillae) extract 10-30 part
Receptaculum nelumbinis extract 20-40 part
Rhizoma nelumbinis extract 20-40 part
Rhizoma Imperatae extract 20-40 part
Flos Sophorae extract 10-30 part
Cacumen Platycladi extract 10-30 part
Radix Notoginseng extract 10-30 part
Pollen Tyjphae extract 10-30 part
Crinis Carbonisatus extract 5-10 part
Herba Clinopodii extract 5-10 part.
8. compound hemostatic material in a kind of multiporous fiber art according to claim 7, it is characterised in that: described Hemostatic of traditional herb medicine extract also comprises the raw material of following weight part:
SIJIQING extract 10-30 part
Lignum Dalbergiae Odoriferae extract 5-10 part
Rhizoma Corydalis extract 20-40 part
Flos Celosiae Cristatae extract 10-30 part
Herba Artemisiae Anomalae extract 10-30 part
Herba Agrimoniae extract 20-40 part
Folium Callicarpae Formosanae extract 10-30 part.
9. the preparation method of compound hemostatic material in a kind of multiporous fiber art according to claim 1, it is characterised in that: micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract are mixed to get compound hemostatic material in a kind of multiporous fiber art.
10. the preparation method of compound hemostatic material in a kind of multiporous fiber art according to claim 9, it is characterised in that: micropore starch, hyaluronic acid, Lasiosphaera fenzlii spore powder and Hemostatic of traditional herb medicine extract continue ultrasonic activation 1-5 hour after mixing.
CN201610042995.7A 2016-01-22 2016-01-22 Porous fiber intraoperative composite hemostatic material and preparation method thereof Pending CN105664230A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610042995.7A CN105664230A (en) 2016-01-22 2016-01-22 Porous fiber intraoperative composite hemostatic material and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610042995.7A CN105664230A (en) 2016-01-22 2016-01-22 Porous fiber intraoperative composite hemostatic material and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105664230A true CN105664230A (en) 2016-06-15

Family

ID=56302066

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610042995.7A Pending CN105664230A (en) 2016-01-22 2016-01-22 Porous fiber intraoperative composite hemostatic material and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105664230A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106620350A (en) * 2017-01-11 2017-05-10 韩秀霞 Fast hemostatic patch for nursing in emergency department

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1442198A (en) * 2002-03-01 2003-09-17 崔建伟 Bullfist blood stanching dressing and its preparation method
CN101002957A (en) * 2007-01-11 2007-07-25 西安三森生物技术有限公司 Biodegradable quick hemostyptic dressing, and its preparing method
CN103349791A (en) * 2013-07-29 2013-10-16 广西信业生物技术有限公司 Novel microporous medical hemostatic material and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1442198A (en) * 2002-03-01 2003-09-17 崔建伟 Bullfist blood stanching dressing and its preparation method
CN101002957A (en) * 2007-01-11 2007-07-25 西安三森生物技术有限公司 Biodegradable quick hemostyptic dressing, and its preparing method
CN103349791A (en) * 2013-07-29 2013-10-16 广西信业生物技术有限公司 Novel microporous medical hemostatic material and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106620350A (en) * 2017-01-11 2017-05-10 韩秀霞 Fast hemostatic patch for nursing in emergency department

Similar Documents

Publication Publication Date Title
CN103349791B (en) Novel microporous medical hemostatic material and preparation method thereof
CN101406557A (en) External-use Chinese medicine for treating burn, scald and various skin injuries
CN105250696A (en) Traditional Chinese medicine gel capable of promoting skin wound to heal and preparation method of traditional Chinese medicine gel
CN105688267A (en) Medical micro-hole composite hemostatic material and preparing method thereof
CN104225258B (en) A kind of Chinese medicine composition promoting wound healing
CN108392672A (en) Radix Notoginseng seaweed gel dressing and preparation method thereof
CN105561383A (en) Composite medical bio-fiber hemostasis modified material and preparation method thereof
CN105688266A (en) Composite medical biofiber bleeding-arresting powder material and preparation method thereof
CN102266373A (en) Skin externally-used matrix for treating scar and preparation method thereof
CN102228635B (en) Wuhuang ointment for treating burn and scald
CN104940627A (en) Traditional Chinese medicine composition for promoting wound healing, and preparation method of traditional Chinese medicine composition
CN105287997A (en) Hemostatic gel for surgery
CN105688268A (en) Novel composite hemostatic material and preparation method of novel composite hemostatic material
CN105457077A (en) Novel composite biological fiber hemostatic powder material and preparation method thereof
CN105664230A (en) Porous fiber intraoperative composite hemostatic material and preparation method thereof
CN102631464B (en) Chinese medicinal ointment for treating infantile hemangioma and preparation method thereof
CN104000918B (en) A kind of external used medicine being used for the treatment of radioactive moist dermatitis
CN103007089B (en) Traditional Chinese medicine composition for treating post-craniocerebral trauma stress ulcer
CN105597141A (en) Porous-fiber composite hemostatic material and preparation method thereof
CN103816247A (en) External Chinese medicinal composition capable of preventing scarring healing of external injury and preparation method for external Chinese medicinal composition
CN102727804B (en) Traditional Chinese medicine composition for treating abscess and boil and preparation method thereof
CN102727725A (en) Pharmaceutical composition for promoting healing of postoperative wound
CN102512573A (en) Nursing liquid for promoting wound healing
CN105561382A (en) Dendrobium officinale liquid woundplast and preparation method thereof
CN108815268A (en) A kind of external application promotees the Chinese medicine ointment formulation and preparation method thereof of union of wounded skin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160615